Home/Healthcare/Medical Devices/Neurorehabilitation Devices Market

Neurorehabilitation Devices Market - Strategic Insights and Forecasts (2026-2031)

Market Size, Share, Growth and Trends Analysis By Type (Neurorobotic Systems, Brain-Computer Interfaces, Wearable Devices, Non-Invasive Stimulators, Neurorehabilitation Gaming Systems, Others), By Application (Stroke, Spinal Cord Injury, Traumatic Brain Injury, Parkinson's Disease, Cerebral Palsy, Others), By End User (Hospitals, Clinics, Rehabilitation Centers, Home Care Settings), and Geography

Market Size in 2025
USD 1.857 billion
Market Size in 2031
USD 3.679 billion
CAGR
12.07%
Study Period
2020-2031
$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

The neurorehabilitation devices market, with a 12.07% CAGR, is expected to grow to USD 3.679 billion in 2031 from USD 1.857 billion in 2025.

Neurorehabilitation Devices Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $1.86B in 2025 to $3.68B by 2031 at a CAGR of 12.07%.
Neurorehabilitation Devices Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $1.86B in 2025 to $3.68B by 2031 at a CAGR of 12.07%.

Highlights:

  1. 1
    Rising neurological disease burden driving market growth
    The neurorehabilitation devices market is expanding steadily due to the increasing prevalence of neurological disorders such as stroke, spinal cord injuries, Parkinson’s disease, and traumatic brain injuries, alongside a rapidly aging global population that requires long-term rehabilitation support.
  2. 2
    Technological advancements enhancing treatment outcomes
    Growth is strongly supported by innovations in neurorobotic systems, brain-computer interfaces, wearable devices, and neurostimulation technologies. The integration of artificial intelligence and data analytics is enabling personalized rehabilitation programs and improving patient recovery outcomes.
  3. 3
    Expanding role of key market players and robotics-based rehabilitation
    Companies such as Abbott Laboratories, Bioness Inc., and Ekso Bionics are driving innovation through neurostimulation devices, functional electrical stimulation systems, and robotic exoskeletons that help restore mobility and neurological function in patients.
  4. 4
    Strong market growth with North America leading globally
    North America dominates the market due to advanced healthcare infrastructure, high prevalence of neurological conditions, strong R&D capabilities, and supportive reimbursement policies. Additionally, increasing government funding and rehabilitation initiatives are further accelerating market expansion across the region.

The neurorehabilitation devices market growth is expanding steadily as the need for improved technologies to help in the recovery and rehabilitation of neurological illnesses and accidents rises. The increased prevalence of neurological diseases and the ageing population have an impact on the neurorehabilitation devices market size. neurorehabilitation devices market growth is being driven by technological breakthroughs such as robots, brain-computer interfaces, and neurostimulation devices. The market's key players possess large neurorehabilitation devices market shares, which contributes to the industry's competitiveness and dynamism. The neurorehabilitation devices market size is predicted to increase further with the continued development of novel devices and therapies and to play a critical role in enhancing the quality of life for those with neurological disabilities.

The Neurorehabilitation Devices market size is growing quickly as there is a more prominent accentuation on improving the personal satisfaction of those experiencing neurological diseases or wounds. Neurorehabilitation devices are expected to assist with the recuperating, recovery, and rebuilding of neurological working by means of centred treatments and medications. Neurostimulation devices, robotics, brain-computer interfaces, wearable sensors, and other technologies are among these gadgets.

Due to the rising prevalence of neurological diseases, technological advancements, and government efforts to support them, the neurorehabilitation devices market growth is expanding rapidly. The neurorehabilitation devices market share is well-positioned to contribute significantly to the enhancement of neurological disease sufferers' quality of life and functional outcomes.

Neurorehabilitation Devices Market Key Players:

  • Abbott Laboratories: Abbott Research facilities, which centers around neurostimulation innovation, is a significant member of the neurorehabilitation gadget industry. Chronic pain, mobility issues, and other neurological diseases are treated with their products. Implantable neurostimulators and outside neurostimulation gadgets are among the items presented by Abbott.

  • Bioness Inc.: Bioness works in the turn of events and the creation of wearable neurorehabilitation gear. Their items incorporate useful electrical feeling (FES) gadgets for upper and lower appendage restoration, which help in the recuperation of development and autonomy in individuals experiencing a stroke, spinal rope injury, and other neurological sicknesses.

  • Ekso Bionics Holdings, Inc.: Ekso Bionics is a trailblazer in exoskeleton innovation for neurorehabilitation. They develop robotic exoskeletons to aid patients with mobility impairments, such as stroke or damage to the spinal cord, in regaining their ability to walk and enhancing their motor function.

Neurorehabilitation Devices Market Drivers:

  • Aging Population and Chronic Diseases:

Neurological conditions like Alzheimer's disease and age-related cognitive decline are more common in the elderly. The rising frequency of these issues expands the interest in neurorehabilitation gadgets that guide in mental preparation, memory improvement, and engine capability upgrade.

  • Rehabilitation Facilities and Healthcare Infrastructure:

The establishment of specialized rehabilitation facilities and the expansion of healthcare infrastructure both contribute to the expansion of the market for neurorehabilitation devices. To provide full rehabilitation services, these facilities require a diverse array of equipment, which presents opportunities for device manufacturers.

  • Integration of Artificial Intelligence and Data Analytics:

The combination of man-made consciousness (man-made intelligence) and information examination in neurorehabilitation gadgets gives energizing improvement possibilities. Information investigation might offer bits of knowledge for streamlining restoration conventions, while artificial intelligence frameworks can examine patient information and make customized treatment programs. This reconciliation considers more viable and proficient recovery treatments, which brings about better persistent results. As medical care experts look for inventive answers for accuracy restoration, the requirement for neurorehabilitation gadgets with simulated intelligence and information investigation capacities is projected to extend.

  • Government Initiatives and Funding Support:

Government measures pointed toward improving admittance to restoration administrations and financing neurorehabilitation research all add to advertise development. Neurorehabilitation gadget financing projects and repayment guidelines urge medical services suppliers to utilize these gadgets, helping market development.

  • The neurorehabilitation devices market is expanding at a steady pace in the forecast period.

The market for neurorehabilitation devices is segmented by type, application, end-user, and geography. Type is further segmented into neurorobotic systems, brain-computer interfaces, wearable devices, non-invasive stimulators, neurorehabilitation gaming systems and others. End-user is further segmented into hospitals, clinics, rehabilitation centers, and home-care settings.

Neurorehabilitation Devices Market Geographical Outlook:

  • North America is a major region in the world, in the neurorehabilitation devices market.

North America dominates the neurorehabilitation devices market share, accounting for a sizable market. Several reasons contribute to its supremacy. To begin, the region has sophisticated healthcare infrastructure, including research and development facilities, allowing for the creation and implementation of novel neurorehabilitation technologies. Second, a high frequency of neurological illnesses and an ageing population fuel the need for appropriate neurorehabilitation treatments. Furthermore, favourable government efforts and reimbursement regulations, as well as significant expenditures in healthcare technology, contribute to neurorehabilitation devices market growth. Major companies and strategic alliances in North America help to increase the company's market position in the Neurorehabilitation Devices market.

Neurorehabilitation Devices Market Key Developments:

  • In May 2023, Medtronic plc, an overall forerunner in medical services innovation, said that it has gone into authoritative arrangements to acquire EOFlow Co. Ltd., the maker of the EOPatch gadget, which is a tubeless, wearable, and very much dispensable insulin conveyance gadget. The expansion of EOFlow, alongside Medtronic's Dinner Recognition Innovation calculation and cutting-edge ceaseless glucose screen, is supposed to widen the organization's capacity to address the issues of additional individuals with diabetes, paying little mind to where they are in their treatment process or how they favour their insulin to be conveyed.

  • In June 2023, Bionik Research Facilities Corp., a mechanical technology organization that offers neurological utilitarian recuperation answers for stroke survivors and others with versatility challenges, as well as administrations to patients in its clinical focuses, is growing its organization with Lifepoint Wellbeing, declaring four new establishments of the InMotion ARM mechanical gadget.

Neurorehabilitation Devices Market Scope:

Report Metric Details
Total Market Size in 2025 USD 1.857 billion
Total Market Size in 2031 USD 3.679 billion
Forecast Unit USD Billion
Growth Rate 12.07%
Study Period 2020 to 2031
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2031
Segmentation Type, Application, End-user, Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies
  • Medtronic plc
  • Abbott Laboratories
  • Ekso Bionics Holdings Inc.
  • Bionik Laboratories Corp.
  • St. Jude Medical (a subsidiary of Abbott Laboratories)

Market Segmentation

By Type

Neurorobotic Systems
Brain-Computer Interfaces
Wearable Devices
Non-Invasive Stimulators
Neurorehabilitation Gaming Systems
Others

By Application

Stroke
Spinal Cord Injury
Traumatic Brain Injury
Parkinson's Disease
Cerebral Palsy
Others

By End-user

Hospitals
Clinics
Rehabilitation Centers
Home Care Settings

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. NEUROREHABILITATION DEVICES MARKET BY TYPE

5.1. Introduction

5.2. Neurorobotic Systems

5.3. Brain-Computer Interfaces

5.4. Wearable Devices

5.5. Non-Invasive Stimulators

5.6. Neurorehabilitation Gaming Systems

5.7. Others     

6. NEUROREHABILITATION DEVICES MARKET BY APPLICATION

6.1. Introduction

6.2. Stroke

6.3. Spinal Cord Injury

6.4. Traumatic Brain Injury

6.5. Parkinson's Disease

6.6. Cerebral Palsy

6.7. Others   

7. NEUROREHABILITATION DEVICES MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Rehabilitation Centers

7.5. Home Care Settings    

8. NEUROREHABILITATION DEVICES MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Medtronic plc

10.2. Abbott Laboratories

10.3. Ekso Bionics Holdings, Inc.

10.4. Bionik Laboratories Corp.

10.5. St. Jude Medical (a subsidiary of Abbott Laboratories)

10.6. Hocoma AG (a subsidiary of DIH International Limited)

10.7. ReWalk Robotics Ltd.

10.8. Tyromotion GmbH

10.9. Kinova Robotics

10.10. Reha-Stim Medtec GmbH & Co. KG        

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061615681
PublishedJan 2026
Pages150
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

The neurorehabilitation devices market is expected to reach a total market size of USD 3.679 billion by 2031.

Neurorehabilitation Devices Market is valued at USD 1.857 billion in 2025.

The neurorehabilitation devices market is expected to grow at a CAGR of 12.07% during the forecast period.

The North American region is anticipated to hold a significant share of the neurorehabilitation devices market.

Prominent key market players in the neurorehabilitation devices market include Medtronic plc, Abbott Laboratories, Ekso Bionics Holdings, Inc., Bionik Laboratories Corp., ReWalk Robotics Ltd., Tyromotion GmbH, among others.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon